The Poznan University of Medical Science and the City of Poznan have the pleasure of inviting for open lectures of the world-famous haematologist, Professor Andrzej Jakubowiak. The lectures will take place on the following dates:
- Multiple Myeloma - Is it Now Curable? - 2 November 2016, at 1.30 p.m., Collegium Anatomicum of the Poznan University of Medical Science of Medical Science, at. Święcickiego Street 6, Poznan, Professor Różycki Lecture Hall (Black Lecture Hall);
- Making career in medicine - 3 November 2016, at 2.00 p.m., Collegium Anatomicum of the Poznan University of Medical Science, at Święcickiego Street 6, Poznan, Professor Różycki Lecture Hall (Black Lecture Hall).
Professor Andrzej Jakubowiak is a world-famous haematologist, specializing in treatment of multiple myeloma. He is the head of a research center on new medicines in haematological therapies at the University of Chicago. He co-operates with the National Cancer Institute, the Multiple Myeloma Research Consortium (MMRC) and with the partners of pharmaceutical industry in searching of innovative solutions in treatment of multiple myeloma, of the newly diagnosed patients, of relapse patients or with myeloma refractory disease. In time of his headship, the Multidisciplinary Multiple Myeloma Clinic at the University of Michigan in Ann Arbor was recognized twice (in 2008 and in 2010) as the best such center in the United States (Myeloma Center of the Year in North America award for myeloma research and drug development).
Professor Jakubowiak is a graduate from the Medical Academy in Poznan of 1977 (PhD dissertation in 1983). After completing a residency of internal diseases at the University of Texas, Health Science Center in Houston was a grant holder of the Weill Cornell Medical College and of Memorial Sloan-Kettering Cancer Center in New York.
Professor has been gladly supporting Polish scientists, also as a Visiting Professor of the Poznan University of Medical Science. He has been closely co-operating at the development of the new platform of studies on multiple myeloma in Poland - the Polish Myeloma Consortium.
In the recent years he has been awarded many awards for his clinical activity and translational researches at the meeting point of science with clinical practice, among others, Multiple Myeloma Research Foundation Accelerator Award for "outstanding achievements and exceptional contribution to swift completion of clinical researches conducted in cooperation with the Multiple Myeloma Research Consortium and the role of the leader of this organization". In 2015, he was awarded a title of a Honorary Member of the Polish Myeloma Study Group, and he has been recently chosen by his colleagues in USA as a "Top Cancer Doctor" in the Newsweek Magazine's and Chicago Magazine's poll.